Volgen
Gerco den Hartog
Titel
Geciteerd door
Geciteerd door
Jaar
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
D Geers, MC Shamier, S Bogers, G den Hartog, L Gommers, ...
Science immunology 6 (59), eabj1750, 2021
5322021
Oxidative stress resulting from Helicobacter pylori infection contributes to gastric carcinogenesis
LD Butcher, G den Hartog, PB Ernst, SE Crowe
Cellular and molecular gastroenterology and hepatology 3 (3), 316-322, 2017
2082017
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
SF Oosting, AAM van der Veldt, CH GeurtsvanKessel, RSN Fehrmann, ...
The Lancet Oncology 22 (12), 1681-1691, 2021
1532021
The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a …
JSF Sanders, FJ Bemelman, AL Messchendorp, CC Baan, D van Baarle, ...
Transplantation 106 (4), 821-834, 2022
1472022
SARS-CoV-2–specific antibody detection for seroepidemiology: a multiplex analysis approach accounting for accurate seroprevalence
G den Hartog, RM Schepp, M Kuijer, C GeurtsvanKessel, J van Beek, ...
The Journal of infectious diseases 222 (9), 1452-1461, 2020
1342020
Successive immunoglobulin and cytokine expression in the small intestine of juvenile chicken
A Lammers, WH Wieland, L Kruijt, A Jansma, T Straetemans, A Schots, ...
Developmental & Comparative Immunology 34 (12), 1254-1262, 2010
1342010
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave
ERA Vos, G den Hartog, RM Schepp, P Kaaijk, J van Vliet, K Helm, ...
J epidemiol community health 75 (6), 489-495, 2021
1022021
Persistence of antibodies to severe acute respiratory syndrome coronavirus 2 in relation to symptoms in a nationwide prospective study
G den Hartog, ERA Vos, LL van den Hoogen, M van Boven, RM Schepp, ...
Clinical Infectious Diseases 73 (12), 2155-2162, 2021
972021
Berberine and obatoclax inhibit SARS-Cov-2 replication in primary human nasal epithelial cells in vitro
FS Varghese, E van Woudenbergh, GJ Overheul, MJ Eleveld, L Kurver, ...
Viruses 13 (2), 282, 2021
642021
Regulation of Rac1 and Reactive Oxygen Species Production in Response to Infection of Gastrointestinal Epithelia
Gerco den Hartog, Ranajoy Chattopadhyay, Amber Ablack, Emily H. Hall ...
PLOS Pathogens 12 (1), e1005382, 2016
642016
Antibody response in immunocompromised patients with hematologic cancers who received a 3-dose mRNA-1273 vaccination schedule for COVID-19
S Haggenburg, Q Hofsink, BI Lissenberg-Witte, AEC Broers, ...
JAMA oncology 8 (10), 1477-1483, 2022
592022
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
S Haggenburg, BI Lissenberg-Witte, RS Van BInnendijk, G Den Hartog, ...
Blood advances 6 (5), 1537-1546, 2022
552022
Associations between measures of social distancing and severe acute respiratory syndrome coronavirus 2 seropositivity: A nationwide population-based study in the Netherlands
ERA Vos, M van Boven, G den Hartog, JA Backer, D Klinkenberg, ...
Clinical Infectious Diseases 73 (12), 2318-2321, 2021
50*2021
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a …
MML Kho, AL Messchendorp, SC Frölke, C Imhof, VJCH Koomen, ...
The Lancet Infectious Diseases 23 (3), 307-319, 2023
482023
Specificity and effector functions of human RSV-specific IgG from bovine milk
G den Hartog, S Jacobino, L Bont, L Cox, LH Ulfman, JHW Leusen, ...
PloS one 9 (11), e112047, 2014
462014
The mucosal factors retinoic acid and TGF-β1 induce phenotypically and functionally distinct dendritic cell types
G Den Hartog, C Van Altena, HFJ Savelkoul, RJJ Van Neerven
International archives of allergy and immunology 162 (3), 225-236, 2013
452013
Decline of RSV-specific antibodies during the COVID-19 pandemic
G den Hartog, PB van Kasteren, RM Schepp, AC Teirlinck, ...
The Lancet Infectious Diseases 23 (1), 23-25, 2023
442023
Safety and immunogenicity of intradermal fractional dose administration of the mRNA-1273 vaccine: a proof-of-concept study
GVT Roozen, MLM Prins, R van Binnendijk, G den Hartog, VP Kuiper, ...
Annals of internal medicine 175 (12), 1771-1774, 2022
38*2022
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
LL van den Hoogen, G Smits, CCE van Hagen, D Wong, ERA Vos, ...
Vaccine 40 (15), 2251-2257, 2022
382022
Modulation of Human Immune Responses by Bovine Interleukin-10
G den Hartog, HFJ Savelkoul, R Schoemaker, E Tijhaar, AH Westphal, ...
PloS one 6 (3), e18188, 2011
352011
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20